Problems identified with phase II stopping rules that employ response and early-progression rates.
Anderson
James R
JR
Krailo
Mark D
MD
D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008962:Models, Theoretical; D012107:Research Design